SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-015152
Filing Date
2021-06-24
Accepted
2021-06-24 08:00:58
Documents
24
Period of Report
2021-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31457
2 ex99-1.htm EX-99.1 17625
3 ex99-1_001.jpg GRAPHIC 51005
4 ex99-1_002.jpg GRAPHIC 109637
5 ex99-1_003.jpg GRAPHIC 35452
6 ex99-1_004.jpg GRAPHIC 68707
7 ex99-1_005.jpg GRAPHIC 60244
8 ex99-1_006.jpg GRAPHIC 47504
9 ex99-1_007.jpg GRAPHIC 29961
10 ex99-1_008.jpg GRAPHIC 29740
11 ex99-1_009.jpg GRAPHIC 71608
12 ex99-1_010.jpg GRAPHIC 77188
13 ex99-1_011.jpg GRAPHIC 64948
14 ex99-1_012.jpg GRAPHIC 59236
15 ex99-1_013.jpg GRAPHIC 82205
16 ex99-1_014.jpg GRAPHIC 72058
17 ex99-1_015.jpg GRAPHIC 70230
18 ex99-1_016.jpg GRAPHIC 66619
19 ex99-1_017.jpg GRAPHIC 25773
20 ex99-1_018.jpg GRAPHIC 67335
21 ex99-1_019.jpg GRAPHIC 65891
22 ex99-1_020.jpg GRAPHIC 82394
23 ex99-1_021.jpg GRAPHIC 39400
24 ex99-1_022.jpg GRAPHIC 17914
  Complete submission text file 0001493152-21-015152.txt   1835939
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 211040610
SIC: 2835 In Vitro & In Vivo Diagnostic Substances